- Home
- CHGG vs BIOA Comparison
CHGG vs BIOA Comparison
Compare CHGG & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- BIOA
- Stock Information
- Founded
- CHGG 2005
- BIOA 2015
- Country
- CHGG United States
- BIOA United States
- Employees
- CHGG N/A
- BIOA N/A
- Industry
- CHGG Other Consumer Services
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- BIOA Health Care
- Exchange
- CHGG Nasdaq
- BIOA Nasdaq
- Market Cap
- CHGG 149.2M
- BIOA 153.4M
- IPO Year
- CHGG 2013
- BIOA 2024
- Fundamental
- Price
- CHGG $1.40
- BIOA $4.28
- Analyst Decision
- CHGG Sell
- BIOA Hold
- Analyst Count
- CHGG 7
- BIOA 4
- Target Price
- CHGG $1.70
- BIOA $5.67
- AVG Volume (30 Days)
- CHGG 5.6M
- BIOA 338.3K
- Earning Date
- CHGG 08-04-2025
- BIOA 08-15-2025
- Dividend Yield
- CHGG N/A
- BIOA N/A
- EPS Growth
- CHGG N/A
- BIOA N/A
- EPS
- CHGG N/A
- BIOA N/A
- Revenue
- CHGG $564,611,000.00
- BIOA $1,451,000.00
- Revenue This Year
- CHGG N/A
- BIOA N/A
- Revenue Next Year
- CHGG N/A
- BIOA N/A
- P/E Ratio
- CHGG N/A
- BIOA N/A
- Revenue Growth
- CHGG N/A
- BIOA N/A
- 52 Week Low
- CHGG $0.44
- BIOA $2.88
- 52 Week High
- CHGG $3.81
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- CHGG 58.00
- BIOA N/A
- Support Level
- CHGG $1.14
- BIOA N/A
- Resistance Level
- CHGG $1.40
- BIOA N/A
- Average True Range (ATR)
- CHGG 0.12
- BIOA 0.00
- MACD
- CHGG -0.02
- BIOA 0.00
- Stochastic Oscillator
- CHGG 66.64
- BIOA 0.00
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.